parthenolide has been researched along with Experimental Hepatoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arai, Y; Inoue, H; Nakai, Y; Nakayama, M; Nishimura, K; Nonomura, N; Oka, D; Okuyama, A; Shiba, M; Takayama, H | 1 |
1 other study(ies) available for parthenolide and Experimental Hepatoma
Article | Year |
---|---|
Sesquiterpene lactone parthenolide suppresses tumor growth in a xenograft model of renal cell carcinoma by inhibiting the activation of NF-kappaB.
Topics: Animals; Apoptosis; Blotting, Western; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Humans; Immunohistochemistry; Interleukin-8; Lactones; Liver Neoplasms, Experimental; Male; Mice; Mice, Nude; NF-kappa B; Phosphorylation; Sesquiterpenes; Time Factors; Tumor Burden; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2007 |